Sustainability | October 14, 2022
JB Pharma publishes its maiden sustainability report
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Plans to double its manufacturing footprint to bolster the growth
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
India's healthcare system has shown great efficiency not only in providing diagnostic and management facilities but also in minimizing mortality and maximizing recovery
The #Heart2HeartChallengeIndia campaign is very simple – you have to climb 60 steps in a minute, make a video of it, share it on your social media, tag 5 people, inviting them to take this challenge to check their heart health
They also noted ProBioGen's digitalization investments and strategy, as well as its support for its employees.
85% of Agilent employees who responded to the survey indicated that the company is a great place to work
SK Capital’s investment will serve as a catalyst for a new strategic direction as the Company seeks to deepen and expand its presence in fine chemistries for the global life science market.
Aimed at improving patient outcomes and increasing connectivity for more efficient monitoring In hospitals and homes
Subscribe To Our Newsletter & Stay Updated
